on DBV TECHNOLOGIES (EPA:DBV)
DBV Technologies to Engage in November Investor Conferences
DBV Technologies, a late-stage biopharmaceutical company based in Châtillon, France, has announced its participation in two upcoming investor conferences this November. The company, known for its work on food allergy treatments, will be attending the Guggenheim Securities 3rd Annual Healthcare Innovation Conference on November 9, 2026, in Boston, MA. This will include a fireside chat at 8:00 am ET, which will be webcast live on DBV's website.
Following this, DBV will engage in one-on-one meetings at the 2026 LifeSci Growth & Innovation Summit in London, UK, on November 16, 2026. Recordings of the Boston fireside chat will remain accessible online for 90 days.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DBV TECHNOLOGIES news